insights_auto
Why is ALCOX up 4.75%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
€0.31
arrow_upward
+4.75%(+0.014) 1D
Oct 9, 5:35:31 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
26.44M
Avg. vol.
170.04K
Volume
90.64K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
26.44M
Avg. vol.
170.04K
Volume
90.64K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
News stories
From web sources and news partners
Traders Union
·
31 minutes ago
Yuriy Matso: S&P500 negative beta to SPY at record 18.9 percent
CryptoRank
·
6 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Hindustan Times
·
2 hours ago
Why are 54% of US stocks down 20% as the S&P 500 nears a record high? | Hindustan Times
24/7 Wall St.
·
7 hours ago
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com